Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ)
CNY 15.52
(-0.83%)
CNY 15.52
(-0.83%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.04 Billion CNY | 6.94% |
| 2022 | 1.91 Billion CNY | 13.02% |
| 2021 | 1.69 Billion CNY | 3.96% |
| 2020 | 1.62 Billion CNY | 85.96% |
| 2019 | 875.86 Million CNY | 36.62% |
| 2018 | 641.12 Million CNY | 33.64% |
| 2017 | 479.73 Million CNY | 52.23% |
| 2016 | 315.14 Million CNY | 42.03% |
| 2015 | 221.88 Million CNY | 28.23% |
| 2014 | 173.04 Million CNY | 61.53% |
| 2013 | 107.13 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.83 Billion CNY | 5.78% |
| 2024 Q1 | 1.73 Billion CNY | -15.08% |
| 2024 Q3 | 1.83 Billion CNY | -0.18% |
| 2023 Q1 | 2.01 Billion CNY | 5.47% |
| 2023 FY | 2.04 Billion CNY | 6.94% |
| 2023 Q4 | 2.04 Billion CNY | -1.82% |
| 2023 Q2 | 2.02 Billion CNY | 0.4% |
| 2023 Q3 | 2.08 Billion CNY | 2.87% |
| 2022 Q4 | 1.91 Billion CNY | 6.04% |
| 2022 FY | 1.91 Billion CNY | 13.02% |
| 2022 Q3 | 1.8 Billion CNY | 6.51% |
| 2022 Q1 | 1.69 Billion CNY | 0.33% |
| 2022 Q2 | 1.69 Billion CNY | -0.26% |
| 2021 Q3 | 1.68 Billion CNY | 4.16% |
| 2021 FY | 1.69 Billion CNY | 3.96% |
| 2021 Q4 | 1.69 Billion CNY | 0.55% |
| 2021 Q2 | 1.61 Billion CNY | 0.25% |
| 2021 Q1 | 1.61 Billion CNY | -0.99% |
| 2020 FY | 1.62 Billion CNY | 85.96% |
| 2020 Q4 | 1.62 Billion CNY | -5.69% |
| 2020 Q2 | 969.88 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q3 | 1.72 Billion CNY | 78.07% |
| 2019 Q4 | 875.86 Million CNY | 0.0% |
| 2019 FY | 875.86 Million CNY | 36.62% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 641.12 Million CNY | 33.64% |
| 2017 FY | 479.73 Million CNY | 52.23% |
| 2016 FY | 315.14 Million CNY | 42.03% |
| 2015 FY | 221.88 Million CNY | 28.23% |
| 2014 FY | 173.04 Million CNY | 61.53% |
| 2013 FY | 107.13 Million CNY | 0.0% |